Global Injectables Drug Delivery devices Market Research Report
- Report Code: IN 1000
- Publish Date: Upcoming
The Global Injectable Drug Delivery Devices Market, mainly driven by a growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer was valued at $11.86 billion in 2013 and expected to be $20.04 billion by 2018, growing at a CAGR of 11.1%.
The report “Global Injectable Drug Delivery Devices Market forecast, 2012-2018 “analyzes the market of devices by segments such as Conventional injectable devices, Self injection devices, other injectable devices.
North America is expected to dominate the overall Injectable Drug Delivery Devices Market in terms of share throughout the forecast period. The presence of growing per capita healthcare expenditures, high patient awareness levels and well defined and supportive reimbursement structure are some of the factors attributing to the aforementioned conclusion.
Europe is the second largest market with major European countries such as Germany, France, Italy, Spain, and UK. Key drivers to drive this market in Europe are the well-established Pharmaceutical market, robust R&D infrastructure, and large investment in R&D.
However, the Asian market is expected to exhibit the highest CAGR during 2013 to 2020. High prevalence of target diseases such as diabetes in emerging economies such as China and India are some of the most significant drivers of this market. The presence of high growth opportunities in emerging Asian economies will ensure a healthy future growth of this market. Constantly improving healthcare infrastructure on account of encouraging government initiatives, the presence of high unmet medical needs and a large base of geriatric population in countries such as Japan and China are some of the other future growth opportunities for this market.
The report also provides an extensive competitive landscaping of companies operating in Injectable Drug Delivery Devices Market. The main companies operating in this market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of diabetes, multiple sclerosis, rheumatoid arthritis, cancer.
- Country specific Patient pool of diabetes, multiple sclerosis, rheumatoid arthritis, cancer
- Disease progression (Pattern analysis)
Pharmacists Forum
- Fast turn-around analysis of Pharmacists response to market events and trends
- Pharmacists opinion about Injectable Drug Delivery products from different companies
- Pharmacists qualitative inputs on epidemiology data
- Pattern analysis of usage of drugs by physicians
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Competitive Intelligence
- The company share analysis of Injectable Drug Delivery Systems for the top players of the market in different countries.
- The crucial developments and strategies of companies inculcating in their portfolio for Injectable Drug Delivery Systems.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices and Self-injection Devices and Microneedles adds up to total |
Upcoming |
|
|
Self-injection Devices Self-injection Devices and Conventional Injectable Drug delivery Devices and Microneedles adds up to total |
Upcoming |
|
|
Prefilled Prefilled and Fillable adds up to total Injectables Drug... |
Upcoming |
|
|
Fillable Fillable and Prefilled adds up to total Injectables Drug... |
Upcoming |
|
|
Disposable Disposable and Reusable adds up to total Injectables Drug... |
Upcoming |
|
|
Reusable Reusable and Disposable adds up to total Injectables Drug... |
Upcoming |
|
|
Standardized Auto Injectors Standardized Auto Injectors and Customized Auto Injectors adds up to total |
Upcoming |
|
|
Customized Auto Injectors Customized Auto Injectors and Standardized Auto Injectors adds up to total |
Upcoming |
|
|
Jet-Based Needle-Free Injectors Jet-Based Needle-Free Injectors and Spring-Based Needle-Free Injectors, |
Upcoming |
|
|
Spring-Based Needle-Free Injectors Spring-Based Needle-Free Injectors and Jet-Based Needle-Free Injectors, |
Upcoming |
|
|
Laser-Based Needle Free Injectors Laser-Based Needle Free Injectors and Jet-Based Needle-Free Injectors, |
Upcoming |
|
|
Vibration-Based Needle Free Injectors Vibration-Based Needle Free Injectors and Jet-Based Needle-Free Injectors, |
Upcoming |
|
|
Automated Auto Injectors Automated Auto Injectors and Manual Auto Injectors adds up to total Auto injectors market. Automated Auto Injectors can be segmented by Products,... |
Upcoming |
|
|
Manual Auto Injectors Manual Auto Injectors and Automated Auto Injectors adds up to total Auto injectors market. Manual Auto Injectors can be segmented by Products,... |
Upcoming |
|
|
Single Chamber Pen Injectors Single Chamber Pen Injectors and Dual Chamber Pen Injectors adds up to total Pen-injectors market. Single Chamber Pen Injectors can be segmented... |
Upcoming |
|
|
Dual Chamber Pen Injectors Dual Chamber Pen Injectors and Single Chamber Pen Injectors adds up to total Pen-injectors market. Dual Chamber Pen Injectors can be segmented... |
Upcoming |
|
|
North American Injectables Drug Delivery devices Market The North American Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $4.6 billion in 2013 and expected to be $7.2 billion by 2018, growing at a CAGR of 9.2%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
European Injectables Drug Delivery devices Market The European Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $3.9 billion in 2013 and expected to be $6.7 billion by 2018, growing at a CAGR of 11.1%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
Asian Injectables Drug Delivery devices Market The Asian Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $2.1 billion in 2013 and expected to be $4.1 billion by 2018, growing at a CAGR of 14.4%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S. |
Upcoming |
|
|
Asia Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices-Asia market has been pegged at 0.0m in the year 2013 growing at annually and is projected to reach 0.0m by the end of the year 2018. It is segmented on basis of . What makes our report unique?... |
Upcoming |
